MAM
EIDX

Meeder Asset Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Meeder Asset Management’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-245
Closed -$3K – 1943
2018
Q4 		$3K Buy
245
+228
+1,341% +$2.79K ﹤0.01% 1546
2018
Q3 		$0 Buy
+17
New – ﹤0.01% 1754